BRIEF—US President to unveil drug pricing plan

Healthcare investors, as well as the pharma industry, will be looking for direction today as US President Donald Trump gives a highly anticipated speech about drug prices.

The plan will reportedly require Medicare Part D plans to share a portion of discounts they receive from drug manufacturers with patients, as well as including ways to allow the government to better negotiate.

Amid concerns over regulation, the S&P 500 healthcare sector has declined about 1% in 2018, underperforming the broader index by more than two percentage points, noted Miles Minkoff, editor of Seeking Alpha.